Takehiko Kaneko, CMO and Head of R&D at Heartseed, is speaking at this year's webinar by American Physiological Society, presenting "Creating New Horizons in Heart Failure Treatment".

Join us on June 23 from 11am-12am EDT to learn more about the pre-clinical studies of our iPSC-derived cardiomyocytes.